Table 2 Baseline characteristics of subject data based on PCOS and MetS subgroups.
Objects | Control (n = 150, 29.01%) | PCOS + nonMetS (n = 175, 33.85%) | PCOS + MetS (n = 192, 37.14%) | F or χ2 | P |
|---|---|---|---|---|---|
General information | |||||
Age (year) | 35.35 ± 6.133 | 35.04 ± 5.577 | 34.85 ± 4.907 | 0.347 | 0.707 |
SBP (mmHg) | 113.93 ± 12.16 | 132.16 ± 19.67 | 150.44 ± 12.86 | 238.863 | 0.000 |
DBP (mmHg) | 68.76 ± 11.58 | 78.49 ± 14.75 | 94.42 ± 10.538 | 188.374 | 0.000 |
PPD (mmHg) | 45.16 ± 10.49 | 54.51 ± 13.24 | 56.08 ± 13.00 | 36.486 | 0.000 |
HR (bpm) | 66.43 ± 10.47 | 78.41 ± 14.53 | 91.64 ± 13.53 | 157.858 | 0.000 |
Anthropometric measurements | |||||
Body weight (kg) | 54.82 ± 5.03 | 64.15 ± 7.41 | 72.93 ± 6.53 | 331.648 | 0.000 |
Body mass index (BMI) | 25.45 ± 2.43 | 28.14 ± 2.35 | 30.46 2.29 | 190.914 | 0.000 |
Waist circumstance (WC) | 73.49 ± 5.32 | 83.59 ± 7.52 | 90.02 ± 7.67 | 234.700. | 0.000 |
Neck circumstance (NC) | 32.29 ± 2.78 | 35.97 ± 2.30 | 39.30 ± 2.09 | 366.127 | 0.000 |
Gonadal hormone concentrations | |||||
Luteinizing hormone (LH, IU/L) | 9.30 ± 1.76 | 9.35 ± 1.80 | 11.43 ± 2.58 | 59.784 | 0.000 |
Follicle stimulating estrogen (FSH, IU/L) | 7.43 ± 1.27 | 6.91 ± 1.23 | 5.84 ± 1.25 | 73.986 | 0.000 |
LH/FSH ratio | 1.24 ± 0.23 | 1.37 ± 0.23 | 2.02 ± 0.49 | 253.175 | 0.000 |
Prolactin (PRL, µg/L) | 9.81 ± 3.15 | 11.33 ± 2.75 | 12.43 ± 3.76 | 26.991 | 0.000 |
Estradiol (E2, pmol/L) | 74.52 ± 31.46 | 64.34 ± 27.29 | 52.50 ± 17.33 | 31.780 | 0.000 |
Testosterone (TE, nmol/L) | 0.84 ± 0.33 | 1.11 ± 0.36 | 1.28 ± 0.47 | 50.628 | 0.000 |
Progesterone (P4, nmol/L) | 0.94 ± 0.21 | 0.88 ± 0.13 | 0.84 ± 0.17 | 12.914 | 0.000 |
Anti-Müllerian tubular hormone (AMH, ng/mL) | 5.98 ± 0 0.80 | 4.84 ± 0.92 | 4.22 ± 1.16 | 136.024 | 0.000 |
Laboratory indicators | |||||
WBC (×10^9/L) | 4.41 ± 0.78 | 5.57 ± 1.06 | 6.42 ± 1.81 | 96.163 | 0.000 |
UA (umol/L) | 177.88 ± 41.67 | 259.57 ± 90.36 | 362.57 ± 98.41 | 213.239 | 0.000 |
BUN (mmol/L) | 5.37 ± 1.49 | 6.54 ± 2.07 | 7.53 ± 2.29 | 48.683 | 0.000 |
Cr (umol/L) | 68.42 ± 16.35 | 80.28 ± 21.85 | 94.06 ± 29.79 | 72.965 | 0.000 |
GFR (ml/min/1.73m2) | 91.55 ± 15.40 | 82.04 ± 18.09 | 66.93 ± 12.76 | 110.705 | 0.000 |
Cystatin C (mg/L) | 0.91 ± 0.36 | 1.49 ± 0.92 | 2.51 ± 1.05 | 154.746 | 0.000 |
FBG (mmol/L) | 5.25 ± 0.43 | 6.32 ± 0.89 | 7.74 ± 1.77 | 179.750 | 0.000 |
HbA1c (mmol/L) | 5.56 ± 0.36 | 6.07 ± 0.46 | 6.52 ± 0.82 | 105.245 | 0.000 |
TC (mmol/L) | 5.92 ± 0.65 | 6.29 ± 0.89 | 7.54 ± 0.88 | 187.275 | 0.000 |
TG (mmol/L) | 1.12 ± 0.32 | 1.85 ± 0.56 | 2.21 ± 0.70 | 160.492 | 0.000 |
LDL-C (mmol/L) | 3.07 ± 0.42 | 3.19 ± 0.60 | 3.91 ± 0.81 | 87.527 | 0.000 |
HDL-C (mmol/L) | 1.73 ± 0.38 | 1.20 ± 0.48 | 0.95 ± 0.22 | 189.500 | 0.000 |
Apo A (g/L) | 1.10 ± 0.30 | 0.97 ± 0.17 | 0.70 ± 0.20 | 140.738 | 0.000 |
Apo B (g/L) | 0.92 ± 0.16 | 1.01 ± 0.22 | 1.15 ± 0.36 | 31.945 | 0.000 |
Apo B/Apo A | 0.88 ± 0.22 | 1.06 ± 0.27 | 1.70 ± 0.59 | 195.030 | 0.000 |
Lp (a) (mmol/L) | 101.21 ± 46.11 | 194.66 ± 93.10 | 359.09 ± 138.39 | 276.782 | 0.000 |
Hcy | 12.74 ± 5.61 | 14.55 ± 6.40 | 19.91 ± 7.75 | 53.944 | 0.000 |
ALT(U/L) | 46.45 ± 18.27 | 50.67 ± 21.90 | 52.70 ± 18.67 | 4.136 | 0.014 |
AST(U/L) | 42.91 ± 9.07 | 43.10 ± 7.97 | 46.11 ± 11.09 | 6.373 | 0.002 |
TyG indexes | 8.42 ± 0.29 | 9.08 ± 0.36 | 9.44 ± 0.41 | 343.437 | 0.000 |
Combined anthropometric and biochemical indicators | |||||
LAP [(WC-58)×TG] | 26.36 ± 9.83 | 64.20 ± 27.78 | 97.08 ± 33.43 | 299.489. | 0.000 |
VAI | 1.13 ± 0.48 | 3.20 ± 1.72 | 4.37 ± 1.73 | 205.053 | 0.000 |
CVAI | 84.53 ± 19.94 | 108.89 ± 21.28 | 125.75 ± 18.15 | 183.263 | 0.000 |
